iNAP Negative Air Pressure Therapy Gains Momentum as CPAP Alternative
An American Heart Association initiative selected the oral negative pressure therapy for its potential to improve heart and brain outcomes in people with OSA.
An American Heart Association initiative selected the oral negative pressure therapy for its potential to improve heart and brain outcomes in people with OSA.
Results from the ATLAST clinical trial of the Winx Sleep Therapy System showed significant improvements in both apnea-hypopnea index (AHI) and oxygen desaturation index (ODI) on the first night of treatment and following 28 days of Winx usage.